265 related articles for article (PubMed ID: 24532579)
1. Distinct pathways of humoral and cellular immunity induced with the mucosal administration of a nanoemulsion adjuvant.
Bielinska AU; Makidon PE; Janczak KW; Blanco LP; Swanson B; Smith DM; Pham T; Szabo Z; Kukowska-Latallo JF; Baker JR
J Immunol; 2014 Mar; 192(6):2722-33. PubMed ID: 24532579
[TBL] [Abstract][Full Text] [Related]
2. Induction of Th17 cellular immunity with a novel nanoemulsion adjuvant.
Bielinska AU; Gerber M; Blanco LP; Makidon PE; Janczak KW; Beer M; Swanson B; Baker JR
Crit Rev Immunol; 2010; 30(2):189-99. PubMed ID: 20370629
[TBL] [Abstract][Full Text] [Related]
3. Nanoemulsion Adjuvant Augments Retinaldehyde Dehydrogenase Activity in Dendritic Cells via MyD88 Pathway.
Farazuddin M; Goel RR; Kline NJ; Landers JJ; O'Konek JJ; Baker JR
Front Immunol; 2019; 10():916. PubMed ID: 31134057
[TBL] [Abstract][Full Text] [Related]
4. Combined Intranasal Nanoemulsion and RIG-I Activating RNA Adjuvants Enhance Mucosal, Humoral, and Cellular Immunity to Influenza Virus.
Wong PT; Goff PH; Sun RJ; Ruge MJ; Ermler ME; Sebring A; O'Konek JJ; Landers JJ; Janczak KW; Sun W; Baker JR
Mol Pharm; 2021 Feb; 18(2):679-698. PubMed ID: 32491861
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity.
Kim WS; Kim H; Kwon KW; Im SH; Lee BR; Ha SJ; Shin SJ
Oncotarget; 2016 Jun; 7(23):33765-82. PubMed ID: 27172902
[TBL] [Abstract][Full Text] [Related]
6. Heat-killed Brucella abortus induces TNF and IL-12p40 by distinct MyD88-dependent pathways: TNF, unlike IL-12p40 secretion, is Toll-like receptor 2 dependent.
Huang LY; Aliberti J; Leifer CA; Segal DM; Sher A; Golenbock DT; Golding B
J Immunol; 2003 Aug; 171(3):1441-6. PubMed ID: 12874236
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant.
Bielinska AU; O'Konek JJ; Janczak KW; Baker JR
Vaccine; 2016 Jul; 34(34):4017-24. PubMed ID: 27317451
[TBL] [Abstract][Full Text] [Related]
8. A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responses.
Xiao L; Kim J; Lim M; Dai B; Yang L; Reed SG; Baltimore D; Wang P
Vaccine; 2012 Mar; 30(15):2570-81. PubMed ID: 22314134
[TBL] [Abstract][Full Text] [Related]
9. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
[TBL] [Abstract][Full Text] [Related]
10. Endotoxin-induced maturation of MyD88-deficient dendritic cells.
Kaisho T; Takeuchi O; Kawai T; Hoshino K; Akira S
J Immunol; 2001 May; 166(9):5688-94. PubMed ID: 11313410
[TBL] [Abstract][Full Text] [Related]
11. New TLR7 agonists with improved humoral and cellular immune responses.
Upchurch KC; Boquín JR; Yin W; Xue Y; Joo H; Kane RR; Oh S
Immunol Lett; 2015 Nov; 168(1):89-97. PubMed ID: 26381186
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles identify both MyD88-independent and MyD88-dependent pathways involved in the maturation of dendritic cells mediated by heparan sulfate: a novel adjuvant.
Wu M; Wang H; Shi J; Sun J; Duan Z; Li Y; Li J; Hu N; Wei Y; Chen Y; Hu Y
Hum Vaccin Immunother; 2014; 10(12):3711-21. PubMed ID: 25668674
[TBL] [Abstract][Full Text] [Related]
13. Non-toxic Stx derivatives from Escherichia coli possess adjuvant activity for mucosal immunity.
Ohmura-Hoshino M; Yamamoto M; Yuki Y; Takeda Y; Kiyono H
Vaccine; 2004 Sep; 22(27-28):3751-61. PubMed ID: 15315856
[TBL] [Abstract][Full Text] [Related]
14.
Pan Q; Zhang Q; Chu J; Pais R; Liu S; He C; Eko FO
Front Cell Infect Microbiol; 2017; 7():514. PubMed ID: 29326885
[TBL] [Abstract][Full Text] [Related]
15. The induction of innate and adaptive immunity by biodegradable poly(γ-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway.
Uto T; Akagi T; Yoshinaga K; Toyama M; Akashi M; Baba M
Biomaterials; 2011 Aug; 32(22):5206-12. PubMed ID: 21492934
[TBL] [Abstract][Full Text] [Related]
16. MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant.
Orr MT; Duthie MS; Windish HP; Lucas EA; Guderian JA; Hudson TE; Shaverdian N; O'Donnell J; Desbien AL; Reed SG; Coler RN
Eur J Immunol; 2013 Sep; 43(9):2398-408. PubMed ID: 23716300
[TBL] [Abstract][Full Text] [Related]
17. Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity.
Uto T; Wang X; Sato K; Haraguchi M; Akagi T; Akashi M; Baba M
J Immunol; 2007 Mar; 178(5):2979-86. PubMed ID: 17312143
[TBL] [Abstract][Full Text] [Related]
18. TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development.
Sun J; Walsh M; Villarino AV; Cervi L; Hunter CA; Choi Y; Pearce EJ
J Immunol; 2005 Jan; 174(2):742-51. PubMed ID: 15634894
[TBL] [Abstract][Full Text] [Related]
19. Neospora caninum glycosylphosphatidylinositols used as adjuvants modulate cellular immune responses induced in vitro by a nanoparticle-based vaccine.
Débare H; Moiré N; Ducournau C; Schmidt J; Laakmann JD; Schwarz RT; Dimier-Poisson I; Debierre-Grockiego F
Cytokine; 2021 Aug; 144():155575. PubMed ID: 34000479
[TBL] [Abstract][Full Text] [Related]
20. PKC-alpha controls MYD88-dependent TLR/IL-1R signaling and cytokine production in mouse and human dendritic cells.
Langlet C; Springael C; Johnson J; Thomas S; Flamand V; Leitges M; Goldman M; Aksoy E; Willems F
Eur J Immunol; 2010 Feb; 40(2):505-15. PubMed ID: 19950169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]